for the moment we have dynamic equilibrium at $1.15 on heavy volume which may well serve to allow structural sellers (Aruda, Aspire) to be replaced by investors with a longer term objectives. I hope the volume keeps up in order that both sides are able to achieve their objectives while serving to clear the market of overhead supply.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links